I have been asked more and more about and why companies are struggling to get the installs and market share they promised to their investors and shareholders. This is across a lot of startups and even some of the bigger companies. It is incredibly relevant in the soft tissue surgical robotics market where we see competitor after competitor struggle to hit the install numbers that even keep up with the incredible market growth.
That has sparked the question "So what is causing this struggle? Why are so many soft tissue surgical robots (companies) struggling?"
I hope this post will help companies avoid some of the quicksand that is dragging some down.
In this short post I'll give ten on my top reasons that I believe other soft tissue surgical robots are struggling. But before I get to the list I need to first set the baseline of what the biggest obstacle is -- Intuitive and their da Vinci robot.
留言